Full Text View
Tabular View
No Study Results Posted
Related Studies
A Phase I Dose-Escalation Study of IMGN388 in Patients With Solid Tumors
This study is currently recruiting participants.
Study NCT00721669   Information provided by ImmunoGen, Inc.
First Received: July 22, 2008   Last Updated: August 4, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Solid Tumor
Additional conditions recognized in this trial
Neoplasms
Interventions listed in this trial
IMGN388
Sponsors listed in this trial
ImmunoGen, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services